Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva)

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 195-201

  Chebolu, Seetha ^a   Wang, Yaozhi ^a   Ray, Andrew P ^a   Darmani, Nissar A ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Dorsal vagal complex; Enteric nervous system; Fos; Leukotriene A4; Leukotriene B4

Indexed keywords

6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE DERIVATIVE; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; PRANLUKAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNOREACTIVITY; INTESTINE INNERVATION; MALE; NONHUMAN; PRIORITY JOURNAL; SHREW; VAGUS NERVE; VOMITING;

ANIMALS; CHROMONES; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS; INSECTIVORA; LEUKOTRIENE C4; LEUKOTRIENES; MALE; PROTO-ONCOGENE PROTEINS C-FOS; SRS-A; VOMITING;

EID: 73649094062     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.030     Document Type: Article

References (31)

1. 1 receptor in nausea and emesis. In: Holzer P. (Ed). Handbook of Experimental Pharmacology (2004), Springer-Verlag, New York 359-440
2. Barnes N. Leukotriene receptor antagonists: clinical effects. J. R. Soc. Med. 90 (1997) 200-204
3. Bhandari P., Bingham S., and Andrews P.L. The neuropharmacology of loperamide-induced emesis in the ferret: the role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacology 31 (1992) 735-742
4. Capra V., Ambrosio M., Riccioni G., and Rovati G.E. Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities. Curr. Med. Chem. 13 (2006) 3213-3226
5. Chio C.C., Baba T., and Black K.L. Selective blood-tumor barrier disruption by leukotrienes. J. Neurosurg. 77 (1992) 407
6. Cordoba-Rodriguez R., Moore K.A., Kao J.P., and Weinreich D. Calcium regulation of a slow post-spike hyperpolarization in vagal afferent neurons. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7650-7657
7. Darmani N.A. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis. J. Neural. Transm. 105 (1998) 1143-1154
8. Darmani N.A. The potent emetogenic effects of the endocannabinoid 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannabinoids. J. Pharmacol. Exp. Therap. 300 (2002) 34-42
9. Darmani N.A., Wang Y., Abad J., Ray A.P., Thrush G.R., and Ramirez J. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists. Brain Res. 1214 (2008) 58-72
10. Darmani N.A., Crim J.L., Janoyan J.J., Abad J., and Ramirez J. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew. Brain Res. 1248 (2009) 40-58
11. Evans J.F. The cysteinyl leukotriene receptors. Prostaglandins Leukot. Essent. Fat. Acids 69 (2003) 117-122
12. Figueroa D.J., Breyer R.M., Defoe S.K., Kargman S., Daugherty B.L., Waldburger K., Liu Q., Clements M., Zeng Z., O'Neill G.P., Jones T.R., Lynch K.R., Austin C.P., and Evans J.F. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 163 (2001) 226-233
13. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R., Williams Jr. D.L., Zeng Z., Liu Q., Ma L., Clements M.K., Coulombe N., Liu Y., Austin C.P., George S.R., O'Neill G.P., Metters K.M., Lynch K.R., and Evans J.F. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275 (2000) 30531-30536
14. Hornby P.J. Central neurocircuitry associated with emesis. Am. J. Med. 111 Suppl 8A (2001) 106S-112S
15. Jedlitschky G., Mayatepek E., and Keppler D. Peroxisomal leukotriene degradation: biochemical and clinical implications. Adv. Enzyme Regul. 33 (1993) 181-194
16. Kan K.K., Jones R.L., Ngan M.P., and Rudd J.A. Action of prostanoids on the emetic reflex of Suncus murinus (the house musk shrew). Eur. J. Pharmacol. 477 (2003) 247-251
17. Kan K.K., Rudd J.A., and Wai M.K. Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret. Eur. J. Pharmacol. 544 (2006) 153-159
18. Kanaoka Y., and Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173 (2004) 1503-1510
19. Koga T., and Fukuda H. Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs. Neurosci. Res. 14 (1992) 166-179
20. Liu S., Hu H.Z., Gao C., Gao N., Wang G., Wang X., Gao X., Xia Y., and Wood J.D. Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine. Eur. J. Pharmacol. 459 (2003) 27-39
21. Liu Y.H., Di Y.M., Zhou Z.W., Mo S.L., and Zhou S.F. Multidrug resistance associated proteins and implications in drug development. Clin. Exp. Pharmacol. Physiol. 37 (2009) 115-120
22. Lord A., Charleson S., and Letts L.G. Leukotriene F4 and the release of arachidonic acid metabolites from perfused guinea pig lungs in vitro. Prostaglandins 29 (1985) 651-660
23. Minami M., Tamakai H., Ogawa T., Endo T., Hamaue N., Hirafuji M., Yoshioka M., and Blower P.R. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine. Res. Commun. Mol. Pathol. Pharmacol. 89 (1995) 131-142
24. Minami M., Endo T., Hirafuji M., Hamaue N., Liu Y., Hiroshige T., Nemoto M., Saito H., and Yoshioka M. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol. Ther. 99 (2003) 149-165
25. Ogasawara H., Ishii S., Yokomizo T., Kakinuma T., Komine M., Tamaki K., Shimizu T., and Izumi T. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J. Biol. Chem. 277 (2002) 18763-18768
26. Ray A.P., Chebolu S., and Darmani N.A. Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva). Pharmacol. Biochem. Behav. 94 (2009) 211-218
27. Ray A.P., Griggs L., and Darmani N.A. Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew. Behav. Brain Res. 196 (2009) 30-36
28. Round A., and Wallis D.I. The depolarizing action of 5-hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205-930. Br. J. Pharmacol. 88 (1986) 485-494
29. Sam T.S., Ngan M.P., Riendeau D., Robichaud A., and Rudd J.A. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret. J. Pharmacol. Sci. 103 (2007) 189-200
30. Slatkin N.E. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. J. Support. Oncol. 5 (2007) 1-9
31. Zaman S., Woods A.J., Watson J.W., Reynolds D.J., and Andrews P.L. The effect of the NK1 receptor antagonist CP-99, 994 on emesis and c-fos protein induction by loperamide in the ferret. Neuropharmacology 39 (2000) 316-323